Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoma 1Leukemia, T-Cell 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1

Interventions

fludarabine phosphate 17Mycophenolic Acid 17Tacrolimus 15Peripheral Blood Stem Cell Transplantation 14Whole-Body Irradiation 13Cyclophosphamide 12Methotrexate 10Cyclosporine 10Busulfan 9Antilymphocyte Serum 9Radiotherapy 7pembrolizumab 5Methylprednisolone 5Bexarotene 5Alemtuzumab 5merphos 4Vorinostat 4Transplantation 4Rituximab 4Melphalan 4Flow Cytometry 4Cord Blood Stem Cell Transplantation 4Brentuximab Vedotin 4Amines 4sargramostim 3mogamulizumab 3hypericin 3Therapeutics 3Sirolimus 3Panobinostat 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Mycosis Fungoides × forodesine × Clear all
NCT00501735 2012-01-23

Forodesine in the Treatment of Cutaneous T-Cell Lymphoma

BioCryst Pharmaceuticals

Phase 2 Completed
144 enrolled
DermatologicLymphoid

Lymphoma, Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡